C-terminal peptides of chemokine-like factor 1 signal through chemokine receptor CCR4 to cross-desensitize the CXCR4

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 356-361

  Zhang, Yan ^a,b   Tian, Linjie ^a,b   Zheng, Yi ^a,b   Qi, Hui ^a,b   Guo, Changyuan ^a,b   Sun, Qianying ^a,b   Xu, Enquan ^a,b   Zhang, Yingmei ^a,b   Ma, Dalong ^a,b   Wang, Ying ^a,b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

CCR4; CKLF1; CXCR4; Desensitization; Peptide; PKC

Indexed keywords

CHEMOKINE LIKE FACTOR 1; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; PEPTIDE C19; PEPTIDE C27; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; STROMAL CELL DERIVED FACTOR 1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; CONTROLLED STUDY; CROSS ALLERGY; DESENSITIZATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTERNALIZATION; PRIORITY JOURNAL;

CHEMOKINE CXCL12; CHEMOKINES; CHEMOTAXIS; DESENSITIZATION, IMMUNOLOGIC; HELA CELLS; HUMANS; HYPERSENSITIVITY; JURKAT CELLS; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; RECEPTORS, CCR4; RECEPTORS, CXCR4;

EID: 79957902152     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.047     Document Type: Article

References (30)

1. McGrath K.E., Koniski A.D., Maltby K.M., McGann J.K., Palis J. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 1999, 213:442-456.
2. Kryczek I., Wei S., Keller E., Liu R., Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am. J. Physiol. Cell Physiol. 2007, 292:C987-C995.
3. Li Y.M., Pan Y., Wei Y., Cheng X., Zhou B.P., Tan M., Zhou X., Xia W., Hortobagyi G.N., Yu D., Hung M.C. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004, 6:459-469.
4. Phillips R.J., Burdick M.D., Lutz M., Belperio J.A., Keane M.P., Strieter R.M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 2003, 167:1676-1686.
5. De Clercq E. The bicyclam AMD3100 story. Nat. Rev. Drug Discov. 2003, 2:581-587.
6. Kelly E., Bailey C.P., Henderson G. Agonist-selective mechanisms of GPCR desensitization. Br. J. Pharmacol. 2008, 153(Suppl. 1):S379-S388.
7. Ali H., Richardson R.M., Haribabu B., Snyderman R. Chemoattractant receptor cross-desensitization. J. Biol. Chem. 1999, 274:6027-6030.
8. Gainetdinov R.R., Premont R.T., Bohn L.M., Lefkowitz R.J., Caron M.G. Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 2004, 27:107-144.
9. Han W., Lou Y., Tang J., Zhang Y., Chen Y., Li Y., Gu W., Huang J., Gui L., Tang Y., Li F., Song Q., Di C., Wang L., Shi Q., Sun R., Xia D., Rui M., Tang J., Ma D. Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem. J. 2001, 357:127-135.
10. Wang Y., Zhang Y., Yang X., Han W., Liu Y., Xu Q., Zhao R., Di C., Song Q., Ma D. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4). Life Sci. 2006, 78:614-621.
11. Li T., Zhong J., Chen Y., Qiu X., Zhang T., Ma D., Han W. Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation. Life Sci. 2006, 79:519-524.
12. Keith J.C., Albert L.M., Leathurby Y., Follettie M., Wang L., Borges-Marcucci L., Chadwick C.C., Steffan R.J., Harnish D.C. The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis. Arthritis Res. Ther. 2005, 7:R427-R438.
13. Tan Y.X., Han W.L., Chen Y.Y., Ouyang N.T., Tang Y., Li F., Ding P.G., Ren X.L., Zeng G.Q., Ding J., Zhu T., Ma D.L., Zhong N.S. Chemokine-like factor 1 a novel cytokine contributes to airway damage remodeling and pulmonary fibrosis. Chin. Med. J. (Engl.) 2004, 117:1123-1129.
14. Wang Y., Zhang Y., Han W., Li D., Tian L., Yin C., Ma D. Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4. Int. J. Biochem. Cell Biol. 2008, 40:909-919.
15. Tian L., Li W., Wang J., Zhang Y., Zheng Y., Qi H., Guo X., Ma D., Shen H., Wang Y. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma. Allergy 2011, 66:287-297.
16. Sun Z., Ling X., Sun W., Xiao J., Yin C., Wang Y. Studies on the interactions between lactam analogs and the N-terminal extracellular tail of CC chemokine receptor 4 by CZE. Electrophoresis 2007, 28:3064-3069.
17. Peng S.B., Peek V., Zhai Y., Paul D.C., Lou Q., Xia X., Eessalu T., Kohn W., Tang S. Akt activation but not extracellular signal-regulated kinase activation is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol. Cancer Res. 2005, 3:227-236.
18. Allen S.J., Crown S.E., Handel T.M. Chemokine: receptor structure, interactions and antagonism. Annu. Rev. Immunol. 2007, 25:787-820.
19. He X., Fang L., Wang J., Yi Y., Zhang S., Xie X. Bryostatin-5 blocks stromal cell-derived factor-1 induced chemotaxis via desensitization and down-regulation of cell surface CXCR4 receptors. Cancer Res. 2008, 68:8678-8686.
20. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E., Sunshine M.J., Littman D.R., Kuo C.J., Wei K., McMaster B.E., Wright K., Howard M.C., Schall T.J. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival cell, adhesion and tumor development. J. Exp. Med. 2006, 203:2201-2213.
21. Neel N.F., Schutyser E., Sai J., Fan G.H., Richmond A. Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev. 2005, 16:637-658.
22. Newhouse B., Allen S., Fauber B., Anderson A.S., Eary C.T., Hansen J.D., Schiro J., Gaudino J.J., Laird E., Chantry D., Eberhardt C., Burgess L.E. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists. Bioorg. Med. Chem. Lett. 2004, 14:5537-5542.
23. Bailey C.P., Smith F.L., Kelly E., Dewey W.L., Henderson G. How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance?. Trends Pharmacol. Sci. 2006, 27:558-565.
24. Churchill E.N., Qvit N., Mochly-Rosen D. Rationally designed peptide regulators of protein kinase C. Trends Endocrinol. Metab. 2009, 20:25-33.
25. Schneider O.D., Weiss A.A., Miller W.E. Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. J. Immunol. 2009, 182:5730-5739.
26. Teicher B.A., Fricker S.P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res. 2010, 16:2927-2931.
27. Richardson R.M., Ali H., Tomhave E.D., Haribabu B., Snyderman R. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity. J. Biol. Chem. 1995, 270:27829-27833.
28. Reiter E., Lefkowitz R.J. GRKs and beta-arrestins: roles in receptor silencing trafficking, and signaling. Trends Endocrinol. Metab. 2006, 17:159-165.
29. Kohout T.A., Nicholas S.L., Perry S.J., Reinhart G., Junger S., Struthers R.S. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J. Biol. Chem. 2004, 279:23214-23222.
30. Adcock I.M., Caramori G., Chung K.F. New targets for drug development in asthma. Lancet 2008, 372:1073-1087.